Bristol-Myers Squibb looks to sell French OTC unit which could bring $1.8B: report
admin 6th July 2018 Uncategorised 0Add Bristol-Myers Squibb to the list of Big Pharmas doing consumer health reevaluations these days. The U.S. drugmaker is looking to sell its French OTC business, Upsa, which could worth up to €1.5 billion, according to Reuters.
More: Bristol-Myers Squibb looks to sell French OTC unit which could bring .8B: report
Source: fierce